Scientific Advisory Board

The Scientific Advisory Board (SAB) is in an advisory capacity for the Board of Trustees and the Scientific Director both regarding scientific and technical issues. The SAB is responsible for the evaluation of FLI’s scientific projects and publication.


Prof. Dr. Magdalena Götz (Head) Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Stem Cell Research, Munich, Germany
Prof. Dr. Rudi Balling (Deputy Head) University of Luxembourg, Luxembourg Centre for Systems Biomedicine, Belval, Luxembourg
Prof. Dr. Carmen Birchmeier-Kohler Max-Delbrück-Centrum für Molekulare Medizin Berlin-Buch, Berlin, Germany
Prof. Dr. Cedric Blanpain Université Libre de Bruxelles, Interdisciplinary Research Institute, Bruxelles, Belgium
Prof. Dr. Gerard Evan University of Cambridge, Head of the Department of Biochemistry, Cambridge, UK
Prof. Dr. Marco Foiani IFOM-IEO Campus, Milan, Italy
Prof. Dr. Eckart D. Gundelfinger Leibniz Institute for Neurobiology, Department Neurochemistry and Molecular Biology, Magdeburg, Germany
Prof. Dr. Volker Haucke Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany
Prof. Dr. Pura Muñoz-Cánoves Pompeu Fabra University, Experimental and Health Services (DCEXS), Barcelona, Spain
Prof. Dr. med. Otto W. Witte University Hospital Jena, Chairman of the Department of Neurology, Jena, Germany
Prof. Dr. Moshe Yaniv Institut Pasteur, Départment de Biologie due Développement, Paris, France
Prof. Dr. med. Lars Zender University of Tübingen, Faculty of Medicine, Head of Section Oncology, Tübingen, Germany